We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
119 hedge funds and large institutions have $151M invested in Invesco Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
155% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 11
118% more capital invested
Capital invested by funds: $69.2M → $151M (+$81.8M)
57% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 21
15.89% more ownership
Funds ownership: 21.99% → 37.88% (+16%)
13% more funds holding
Funds holding: 105 → 119 (+14)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $259K
Holders
119
Holders Change
+14
Holders Change %
+13.33%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
33
Reduced
21
Closed
11
Calls
–
Puts
$259K
Net Calls
-$259K
Net Calls Change
-$259K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$24.4M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$23.4M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$5.51M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.45M |
| 5 |
CI
Cavalier Investments
Alpharetta,
Georgia
|
+$4.85M |
